Your browser doesn't support javascript.
loading
Orally active αvß3 integrin inhibitor MK-0429 reduces melanoma metastasis.
Pickarski, Maureen; Gleason, Alexa; Bednar, Bohumil; Duong, Le T.
Affiliation
  • Pickarski M; Bone Biology, Merck Research Laboratories, West Point, PA 19486, USA.
  • Gleason A; Imaging, Merck Research Laboratories, West Point, PA 19486, USA.
  • Bednar B; Imaging, Merck Research Laboratories, West Point, PA 19486, USA.
  • Duong LT; Bone Biology, Merck Research Laboratories, West Point, PA 19486, USA.
Oncol Rep ; 33(6): 2737-45, 2015 Jun.
Article in En | MEDLINE | ID: mdl-25872534
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propionates / Melanoma, Experimental / Integrin alphaVbeta3 / Lung Neoplasms / Melanoma / Naphthyridines Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: United States Country of publication: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propionates / Melanoma, Experimental / Integrin alphaVbeta3 / Lung Neoplasms / Melanoma / Naphthyridines Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: United States Country of publication: Greece